APA (7th ed.) Citation

H, L., Y, S., T, I., Y, M., X, C., T, L., . . . T, M. (2026). Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects. Circulation journal : official journal of the Japanese Circulation Society, 90(6), 616. https://doi.org/10.1253/circj.CJ-25-0757

Chicago Style (17th ed.) Citation

H, Luo, et al. "Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects." Circulation Journal : Official Journal of the Japanese Circulation Society 90, no. 6 (2026): 616. https://doi.org/10.1253/circj.CJ-25-0757.

MLA (9th ed.) Citation

H, Luo, et al. "Therapeutic Lymphangiogenesis Using Induced Cardiac Fibroblasts Protects the Heart From Heart Failure With Preserved Ejection Fraction Progression by Exerting Anti-Inflammatory and Antifibrotic Effects." Circulation Journal : Official Journal of the Japanese Circulation Society, vol. 90, no. 6, 2026, p. 616, https://doi.org/10.1253/circj.CJ-25-0757.